IRIS Institutional Research Information System - OPENBS Open Archive UniBS

GRISANTI, Salvatore
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.478
AS - Asia 5.210
EU - Europa 3.686
SA - Sud America 1.058
AF - Africa 145
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 3
Totale 19.590
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.281
SG - Singapore 2.068
CN - Cina 1.420
BR - Brasile 850
IT - Italia 723
HK - Hong Kong 544
DE - Germania 485
UA - Ucraina 450
VN - Vietnam 418
PL - Polonia 417
FI - Finlandia 407
FR - Francia 269
RU - Federazione Russa 227
GB - Regno Unito 217
TR - Turchia 171
IE - Irlanda 136
IN - India 132
CA - Canada 107
AR - Argentina 79
BD - Bangladesh 72
ID - Indonesia 66
SE - Svezia 66
JP - Giappone 57
CZ - Repubblica Ceca 56
NL - Olanda 55
IQ - Iraq 53
MX - Messico 51
ZA - Sudafrica 50
AT - Austria 33
PK - Pakistan 33
EC - Ecuador 32
BE - Belgio 28
ES - Italia 28
UZ - Uzbekistan 23
CO - Colombia 21
MA - Marocco 21
SA - Arabia Saudita 21
VE - Venezuela 18
AE - Emirati Arabi Uniti 17
PY - Paraguay 17
LT - Lituania 14
CL - Cile 13
EG - Egitto 13
PH - Filippine 13
AZ - Azerbaigian 12
CH - Svizzera 12
DZ - Algeria 12
GR - Grecia 12
PE - Perù 12
JO - Giordania 11
PT - Portogallo 11
KE - Kenya 10
AU - Australia 9
CR - Costa Rica 8
LB - Libano 8
NG - Nigeria 8
NP - Nepal 8
PA - Panama 8
AL - Albania 7
IL - Israele 7
JM - Giamaica 7
UY - Uruguay 7
ET - Etiopia 6
TH - Thailandia 6
TN - Tunisia 6
TW - Taiwan 6
IR - Iran 5
KZ - Kazakistan 5
LY - Libia 5
BG - Bulgaria 4
CY - Cipro 4
DO - Repubblica Dominicana 4
GY - Guiana 4
KG - Kirghizistan 4
KR - Corea 4
LV - Lettonia 4
MU - Mauritius 4
MY - Malesia 4
OM - Oman 4
RO - Romania 4
BO - Bolivia 3
DK - Danimarca 3
EE - Estonia 3
EU - Europa 3
HN - Honduras 3
LK - Sri Lanka 3
RS - Serbia 3
AO - Angola 2
BB - Barbados 2
MD - Moldavia 2
NO - Norvegia 2
QA - Qatar 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
TG - Togo 2
TT - Trinidad e Tobago 2
ZW - Zimbabwe 2
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 19.569
Salva come PNG Salva come JPEG
Città #
Singapore 1.108
Ashburn 950
Fairfield 746
Hong Kong 534
Woodbridge 532
San Jose 529
Warsaw 410
Houston 399
Dallas 338
The Dalles 328
Seattle 313
Jacksonville 309
Cambridge 306
Beijing 304
Chandler 301
New York 283
Los Angeles 279
Wilmington 266
Chicago 263
Helsinki 263
Princeton 178
Ann Arbor 166
Lauterbourg 152
Ho Chi Minh City 144
Munich 142
Istanbul 135
Council Bluffs 132
Salt Lake City 110
Dublin 104
Buffalo 100
Brescia 98
Moscow 90
Nanjing 87
São Paulo 82
Turku 78
Shanghai 75
Milan 73
Boardman 72
Hanoi 72
Redondo Beach 66
Des Moines 60
San Francisco 57
Secaucus 56
Tampa 52
Elk Grove Village 51
Jakarta 51
Santa Clara 51
Dearborn 50
London 45
Orem 44
Brno 42
Lancaster 42
Changsha 38
Brooklyn 37
Nanchang 37
San Diego 35
Montreal 34
Frankfurt am Main 33
Nuremberg 33
Tokyo 33
Dong Ket 32
Chennai 31
Poplar 31
Washington 31
Dalmine 30
Rio de Janeiro 30
Romola 29
Stockholm 29
Lappeenranta 28
Sterling 28
Shenyang 27
Brussels 26
Da Nang 26
Naples 26
Tianjin 26
West Jordan 26
Phoenix 25
Rome 25
Belo Horizonte 24
Boston 24
Denver 24
Toronto 24
Atlanta 22
Guangzhou 22
Johannesburg 22
Menlo Park 22
Jinan 21
Tashkent 21
Amsterdam 20
Haiphong 20
Vienna 20
Bergamo 19
Hangzhou 19
Ankara 18
Zhengzhou 17
Curitiba 16
Dulles 16
Hebei 16
Manchester 16
Paris 16
Totale 12.743
Salva come PNG Salva come JPEG
Nome #
Cytotoxic Effect of Progesterone, Tamoxifen and Their Combination in Experimental Cell Models of Human Adrenocortical Cancer 787
Efficacy of the EDP-M Scheme Plus Adjunctive Surgery in the Management of Patients with Advanced Adrenocortical Carcinoma: The Brescia Experience. 378
Are we failing in treatment of adrenocortical carcinoma? Lights and shadows of molecular signatures 251
In vitro cytotoxicity of cabazitaxel in adrenocortical carcinoma cell lines and human adrenocortical carcinoma primary cell cultures☆ 247
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcoma 246
Biological effect of neoadjuvant androgen-deprivation therapy assessed on specimens from radical prostatectomy: a systematic review 245
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 226
Cytotoxic Effect of Trabectedin In Human Adrenocortical Carcinoma Cell Lines and Primary Cells 221
Immunotherapy failure in adrenocortical cancer: where next? 220
Panniculitis and vitiligo occurring during BRAF and MEK inhibitors combination in advanced melanoma patients: Potential predictive role of treatment efficacy 212
A neuro-oncologic challenge: the case of a large, aggressive, malignant meningioma of the skull base with paranasal sinus involvement 210
Post-surgical therapeutic approaches to glioblastoma patients submitted to biopsy (BA) or "partial" resection (PR): the possibilities to treat also them without renunciations. Study from the Brescia Neuro-Oncology Group 209
Management of Severe Cushing Syndrome Induced by Adrenocortical Carcinoma with Abiraterone Acetate: A Case Report 207
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Dental pathologies and osteoradionecrosis (Part 1) literature review and consensus statement 205
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinoma 203
Cetuximab and Radiotherapy Versus Cisplatin and Radiotherapy for Locally Advanced Head and Neck Cancer: A Randomized Phase II Trial 199
Molecular Drivers of Potential Immunotherapy Failure in Adrenocortical Carcinoma. 197
Adrenocortical Carcinoma and CT Assessment of Therapy Response: The Value of Combining Multiple Criteria 197
EGFR amplified and overexpressing glioblastomas and association with better response to adjuvant metronomic temozolomide 195
Subgroup Analysis According to Human Papillomavirus Status and Tumor Site of a Randomized Phase II Trial Comparing Cetuximab and Cisplatin Combined With Radiation Therapy for Locally Advanced Head and Neck Cancer 190
Topoisomerase 2α and thymidylate synthase expression in adrenocortical cancer 184
Analysis of Circulating Tumor Cells in Prostate Cancer Patients at PSA Recurrence and Review of the Literature 181
Sacituzumab govitecan and radiotherapy in metastatic, triple-negative, and BRCA-mutant breast cancer patient with active brain metastases: A case report 179
Antineoplastic Activity of Artemisinin in Adrenocortical Carcinoma 178
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients 177
Oral toxicity management in head and neck cancer patients treated with chemotherapy and radiation: Xerostomia and trismus (Part 2). Literature review and consensus statement 175
Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer 171
Different management of adrenocortical carcinoma in children compared to adults: is it time to share guidelines? 169
Cetuximab in the treatment of metastatic mucoepidermoid carcinoma of the salivary glands: a case report and review of literature. 168
Second line treatment of recurrent glioblastoma with sunitinib: results of a phase II study and systematic review of literature 168
Is time to first skeletal-related event the best primary end point in the assessment of bisphosphonate efficacy in patients with castration-sensitive prostate cancer? 166
Eribulin Treatment in Patients with Liver Metastatic Breast Cancer: Eight Italian Case Reports 165
Glutamine synthetase expression as a valuable marker of epilepsy and longer survival in newly diagnosed glioblastoma multiforme 161
Leptomeningeal metastasis from solid tumors: a diagnostic and therapeutic challenge. 161
CETUXIMAB AND RADIOTHERAPY VERSUS CISPLATIN AND RADIOTHERAPY FOR LOCALLY ADVANCED HEAD AND NECK CANCER: LONG TERM SURVIVAL AND TOXICITY OUTCOMES OF A RANDOMIZED PHASE II TRIAL 161
Circulating Tumour Cells in locally advanced head and neck cancer: Preliminary report about their possible role in predicting response to non-surgical treatment and survival. 156
Molecular target agents in adrenocortical carcinoma: rationale and difficulties in trial design 153
Circulating tumor cells in patients with recurrent or metastatic head and neck carcinoma: prognostic and predictive significance 153
The Spread of SARS-CoV-2 Infection Among the Medical Oncology Staff of ASST Spedali Civili of Brescia: Efficacy of Preventive Measures 152
Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli 150
Aspergillosis superinfection as a cause of death of crizotinib-induced interstitial lung disease successfully treated with high-dose corticosteroid therapy 150
Eribulin in Heavily Pretreated Metastatic Breast Cancer Patients in the Real World: A Retrospective Study 149
Gemcitabine plus celecoxib (GECO) in advanced pancreatic cancer: a phase II trial 147
Circulating Tumour Cells in Clinical Practice: Can Lessons Learned From Locally Advanced/Metastatic Breast and Prostate Cancers Guide Their use for other Cancer Types? Lights and Shadows 145
An alternating regimen of irinotecan/ 5-fluorouracil/folinic acid and oxaliplatin/ 5-fluorouracil/folinic acid in metastatic colorectal cancer: a Phase II trial 138
Bone metastases from head and neck malignancies: Prognostic factors and skeletal-related events 138
Retreatment of recurrent adult medulloblastoma with radiotherapy: a case report and review of the literature. 138
Ribociclib Cytotoxicity Alone Or Combined With Progesterone And/Or Mitotane In In Vitro Adrenocortical Carcinoma Cells 138
The impact of tumor histology and recursive partitioning analysis classification on the prognosis of patients treated with whole-brain hypofractionated radiotherapy for brain metastases: analysis of 382 patients 137
Clinical presentation and outcome of patients with enteric-type adenocarcinoma of the lung: A pooled analysis of published cases 136
The impact of the histology of primary tumor on RPA prognostic classifications in patients (pts) treated for brain metastases (BM). Retrospective analysis of 382 pts treated with hypofractionated whole brain radiotherapy (HWBRT). 136
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial 135
Progression of vertebral fractures in metastatic melanoma and non-small cell lung cancer patients given immune checkpoint inhibitors 134
Systemic Therapy in Locally Advanced or Metastatic Adrenal Cancers: A Critical Appraisal and Clinical Trial Update 134
Idiopathic intracranial hypertension: A possible complication in the natural history of advanced prostate cancer. 131
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution. 130
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors 130
Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic 130
Radiotherapy in low-grade glioma adult patients: a retrospective survival and neurocognitive toxicity analysis. 128
Outcome of patients with intrathyroidal thymic carcinoma: a pooled analysis 127
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study 126
Hyperthermic Intraperitoneal Chemotherapy for Primary or Recurrent Adrenocortical Carcinoma. A Single Center Study. 125
Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma 124
HER-2 overexpression/amplification in Barrett's oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study. 123
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical Carcinoma 123
Ovarian Strumal Carcinoid: Case Report, Systematic Literature Review and Pooled Analysis 122
Advances in adrenocortical carcinoma pharmacotherapy: what is the current state of the art? 122
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 121
Preclinical Evidence of Progesterone as a New Pharmacological Strategy in Human Adrenocortical Carcinoma Cell Lines 120
Phase II study of sunitinib and irinotecan in patients with recurrent high-grade glioma (HGG) 119
Is androgen deprivation therapy protective against SARS-CoV-2 infection and related complications in prostate cancer patients? 118
Androgen serum levels in male patients with adrenocortical carcinoma given mitotane therapy: A single center retrospective longitudinal study 116
Estrogen-Like Effect of Mitotane Explained by Its Agonist Activity on Estrogen Receptor-α 115
Microvascular Structural Alterations in Cancer Patients Treated With Antiangiogenic Drugs 113
Supportive therapies in patients with advanced adrenocortical carcinoma submitted to standard EDP-M regimen 112
Adverse skeletal related events in patients with bone-metastatic pheochromocytoma/paraganglioma 110
Treatment and outcome of metastatic parathyroid carcinoma: A systematic review and pooled analysis of published cases 110
Clinical Prognostic Factors in Patients With Metastatic Adrenocortical Carcinoma Treated With Second Line Gemcitabine Plus Capecitabine Chemotherapy 109
Prognostic role of overt hypercortisolism in completely operated patients with adrenocortical cancer. 109
Trabectedin impairs invasiveness and metastasis in adrenocortical carcinoma preclinical models 107
Feasibility and Activity of Megestrol Acetate in Addition to Etoposide, Doxorubicin, Cisplatin, and Mitotane as First-Line Therapy in Patients with Metastatic/Unresectable Adrenocortical Carcinoma with Low Performance Status 107
Outcome of brain metastases from adrenocortical carcinoma: a pooled analysis 105
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 105
Taste Alterations Do Not Affect Change in Food Habits and Body Weight in Breast Cancer Patients 104
Oncological treatment administration at end of life: a retrospective study 104
Evaluation of DNA methylation levels of SEPT9 and SHOX2 in plasma of patients with head and neck squamous cell carcinoma using droplet digital PCR 103
The long and winding road to effective immunotherapy in patients with adrenocortical carcinoma 103
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 100
Home-based pulmonary rehabilitation in patients undergoing (chemo)radiation therapy for unresectable lung cancer: a prospective explorative study 100
Case Report: 18F-PSMA PET/CT Scan in Castration Resistant Prostate Cancer With Aggressive Neuroendocrine Differentiation 100
Comparison of the prognostic classification with recursive partitioning analysis (RPA) and general prognostic assessment (GPA) in a retrospective analysis of 430 patients with brain metastases 99
Network indirect comparison of 3 BRAF + MEK inhibitors for the treatment of advanced BRAF mutated melanoma 97
Outcome of Patients With Metastatic Lung Neuroendocrine Tumors Submitted to First Line Monotherapy With Somatostatin Analogs 97
Letter to the editor from Berruti et al: "Cytoreductive Surgery of the Primary Tumor in Metastatic Adrenocortical Carcinoma: Impact on Patients' Survival" 97
Dynamic Susceptibility Contrast MR Imaging inGlioblastomas: Correlation of Whole-TumorHistogram Analysis of the Normalized CerebralBlood Volume and Vascular Permeability withHistopathologic and Molecular Markers of TumorAggressiveness 96
Needs in breast cancer patients (pts) during chemotherapy: Customer satisfaction evaluation 95
Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: Does dietary counseling matter? 95
Immune-related adverse events as potential surrogates of immune checkpoint inhibitors’ efficacy: a systematic review and meta-analysis of randomized studies 92
Frequency and outcome of SARS-CoV-2 infection in patients with adrenocortical carcinoma followed at a reference center in Italy 90
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinoma 89
Totale 15.426
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021454 0 0 0 0 0 0 0 0 0 214 123 117
2021/2022848 67 82 30 96 22 53 36 56 43 108 64 191
2022/2023823 106 53 42 63 70 191 5 74 119 22 44 34
2023/20241.474 71 41 133 93 104 269 46 79 226 69 49 294
2024/20254.477 50 47 62 557 406 297 276 151 457 288 1.014 872
2025/20267.399 667 1.045 733 955 793 554 1.171 333 555 593 0 0
Totale 19.913